Ischemic heart disease in women presents differently than in men, often involving endothelial dysfunction rather than critical stenosis, and requires tailored risk factor modification.
Answers are grounded in this paper and cite their sources.
Requires sex-specific IHD symptom assessment in women; leaves open effective primary prevention options under age 65.
Ischemic heart disease (IHD) is the leading cause of death among women in the Western world, and its prevalence is growing. The pathophysiology of heart disease in women differs from that in men. Women with chest pain and abnormal stress tests are less likely than men to have critical stenosis of coronary arteries, a phenomenon attributed to endothelial dysfunction. Hypertension, intimal injury, and cholesterol are among the various factors that contribute to endothelial dysfunction. The presenting symptoms of IHD also differ in women. Women are more likely to describe neck and throat pain and to characterize the pain as intense, sharp, or burning. A history of coronary or other vascular disease, diabetes, or chronic kidney disease places patients at high risk for IHD. Risk factor modification can be tailored based on each patient's risk. Hormone replacement therapy, antioxidants, folic acid, and aspirin in healthy women under 65 years of age have recently been shown to be ineffective in the prevention of IHD.
No takes yet. Share an insight, caveat, or question.
Kusnoor et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: